Metronidazol Normon

Metronidazole, the active ingredient in Metronidazol Normon, is a nitroimidazole antibiotic presented as an oral dosage form for oral use. It treats infections caused by anaerobic bacteria and certain protozoa in adults and children when prescribed, and is indicated for a range of bacterial and protozoal infections and is part of standard treatment guidelines.

GNH USA supplies Metronidazol Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across multiple markets.

Metronidazole is used to treat infections caused by anaerobic bacteria and susceptible protozoa. - Bacterial vaginosis: eliminates the anaerobic bacteria responsible for the condition, restoring normal vaginal flora. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebiasis: clears intestinal Entamoeba histolytica infection, reducing dysentery and liver abscess risk. - Giardiasis: treats Giardia lamblia infection, alleviating diarrhea and malabsorption. - Anaerobic bacterial infections: controls intra‑abdominal, skin and bone infections caused by susceptible anaerobes.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Metallic taste - Headache - Diarrhea

Serious or Rare Side Effects: - Seizures - Peripheral neuropathy - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Before using Metronidazol Normon, consider the following precautions. - Pregnancy: Category B; use only when the benefit outweighs potential risk. - Alcohol: Avoid concurrent alcohol consumption due to a disulfiram‑like reaction. - Renal impairment: Assess renal function and adjust dose if necessary. - Hepatic disease: Use with caution; monitor liver enzymes. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Metronidazol Normon can interact with several medicines; review them with a healthcare professional.

Major Interactions (Avoid): - Alcohol: may cause severe nausea, vomiting and flushing. - Warfarin: potentiates anticoagulant effect, increasing INR and bleeding risk. - Lithium: may raise lithium serum levels, leading to toxicity. - Cimetidine: can increase metronidazole plasma concentrations.

Moderate Interactions (Monitor Closely): - Phenobarbital: may reduce metronidazole efficacy by increasing metabolism. - Carbamazepine: may lower plasma levels, decreasing therapeutic effect. - Oral contraceptives: may reduce hormonal efficacy; consider alternative contraception.